ChemoCentryx (CCXI) Announces Presentation of Positive CCR2, C5aR Data at ERA-EDTA Congress
Tweet Send to a Friend
ChemoCentryx (NASDAQ: CCXI) announced data presentations from two of its chemoattractant receptor programs, CCR2 and C5aR, at the 52nd European ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
